Alector (ALEC) Cash & Equivalents (2018 - 2026)
Alector (ALEC) posted quarterly Cash & Equivalents of $77.0 million for Q1 2026, up 102.68% year-over-year from $38.0 million in Q1 2025, and up 16.96% quarter-over-quarter from $65.8 million in Q4 2025.
Alector (ALEC) Cash & Equivalents (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Cash & Equivalents for 9 consecutive years, with $77.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents rose 102.68% year-over-year to $77.0 million; the TTM figure through Mar 2026 stood at $77.0 million (up 102.68% YoY), while the FY2025 annual figure was $65.8 million, up 99.27% from the prior year.
- Cash & Equivalents advanced to $77.0 million in Q1 2026 per ALEC's latest filing, from $65.8 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $454.6 million in Q1 2022 and bottomed at $33.0 million in Q4 2024.
- Historically, Cash & Equivalents has averaged $115.4 million across 5 years, with a median of $76.5 million in 2025.
- On a YoY basis, Cash & Equivalents climbed as much as 310.67% in 2022 and fell as far as 64.33% in 2022.
- Alector's Cash & Equivalents stood at $154.3 million in 2022, then tumbled by 51.69% to $74.6 million in 2023, then slumped by 55.71% to $33.0 million in 2024, then jumped by 99.27% to $65.8 million in 2025, then climbed by 16.96% to $77.0 million in 2026.
- Business Quant data shows ALEC's Cash & Equivalents at $77.0 million in Q1 2026, $65.8 million in Q4 2025, and $76.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 6.14 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.46 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 3.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 815.44 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.37 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.99 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.71 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 544.80 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 59.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.92 Mn |
| Mar 31, 2026 | 76.96 Mn |
| Dec 31, 2025 | 65.80 Mn |
| Sep 30, 2025 | 76.50 Mn |
| Jun 30, 2025 | 44.77 Mn |
| Mar 31, 2025 | 37.97 Mn |
| Dec 31, 2024 | 33.02 Mn |
| Sep 30, 2024 | 37.16 Mn |
| Jun 30, 2024 | 47.55 Mn |
| Mar 31, 2024 | 72.55 Mn |
| Dec 31, 2023 | 74.56 Mn |
| Sep 30, 2023 | 101.96 Mn |
| Jun 30, 2023 | 131.54 Mn |
| Mar 31, 2023 | 195.56 Mn |
| Dec 31, 2022 | 154.32 Mn |
| Sep 30, 2022 | 184.23 Mn |
| Jun 30, 2022 | 172.27 Mn |
| Mar 31, 2022 | 454.62 Mn |
| Dec 31, 2021 | 329.15 Mn |
| Sep 30, 2021 | 516.53 Mn |